Thermo Fisher Scientific Total Current Assets increased by 28.8% to $28.71B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.7%, from $22.14B to $28.71B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 5.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A high ratio of current assets to current liabilities indicates strong short-term solvency and financial health.
The sum of all assets expected to be converted into cash or consumed within one fiscal year. This provides a snapshot of...
Used to calculate the Current Ratio, a standard benchmark for liquidity across the S&P 500.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.26B | $24.72B | $20.11B | $18.78B | $18.10B | $19.30B | $25.23B | $20.21B | $20.00B | $23.09B | $24.59B | $23.64B | $25.48B | $23.78B | $22.14B | $23.38B | $24.58B | $22.30B | $28.71B |
| QoQ Change | — | +28.4% | -18.6% | -6.6% | -3.6% | +6.6% | +30.7% | -19.9% | -1.1% | +15.5% | +6.5% | -3.9% | +7.8% | -6.6% | -6.9% | +5.6% | +5.2% | -9.3% | +28.8% |
| YoY Change | — | — | — | — | -6.0% | -21.9% | +25.4% | +7.6% | +10.5% | +19.7% | -2.5% | +17.0% | +27.4% | +3.0% | -10.0% | -1.1% | -3.5% | -6.3% | +29.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.